Home › NDC Lookup › Ingredients › Loratadine And Pseudoephedrine Sulfate › 37808-0787-07
Allergy Relief-D LORATADINE AND PSEUDOEPHEDRINE SULFATE 240 mg; 10 mg Tablet, Extended Release — NDC 37808-0787-07 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Allergy Relief-D LORATADINE AND PSEUDOEPHEDRINE SULFATE 240 mg; 10 mg Tablet, Extended Release — NDC 37808-787-07 (Billing 37808-0787-07)

by HEB · 2 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of Allergy Relief-D LORATADINE AND PSEUDOEPHEDRINE SULFATE 240 mg; 10 mg Tablet, Extended Release from HEB, marketed since May 2025 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 37808-0787-07
🏷️ FDA NDC (as labeled) 37808-787-07 billing pads the product segment with a zero
This package
Contains5 tablet, extended release in 1 blister pack Pack sizes2 compare ↓
Main listing for product 37808-787 · Also comes in: 5 tablets 37808-787-35
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 37808-787-07 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
37808 labeler · 787 product · 07 package
Package marketed since
May 27, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 3780878707 0
FDA record last changed
Aug 27, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 37808-787-07
Product NDC 37808-787
11-digit billing NDC 37808078707
RxCUI 1117562
UNII Y9DL7QPE6B, 7AJO3BO7QN
Application # ANDA218017
SPL Set ID 36230417-8687-d9fd-e063-6394a90ac2e5
Established class (EPC) alpha-Adrenergic Agonist
Mechanism of action Adrenergic alpha-Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-05-27
Route ORAL
Dosage form TABLET, EXTENDED RELEASE
Substance PSEUDOEPHEDRINE SULFATE; LORATADINE
Quick answers
  • RxCUI (RxNorm): 1117562
Why two NDCs? The FDA registers this code as 37808-787-07 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 37808-0787-07. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antihistamines for systemic use class.

Drug family (ATC) Other antihistamines for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Loratadine is used to treat allergy symptoms: sneezing runny nose itching of the nose or throat red, itchy, or watery eyes Loratadine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves allergy symptoms like sneezing, runny nose, itchy, watery eyes, and itching of the nose or throat. It also relieves nasal and sinus congestion from allergie...
  • Swallow the tablet whole with a full glass of water. Never split, crush, chew or dissolve it. Some products are once a day and others are every 12 hours, so check your box and foll...
  • Not if it is an MAOI, or if you stopped one within the last 2 weeks. MAOIs are used for certain depression, psychiatric conditions, and Parkinson's disease. If you are unsure, ask...
  • Taking more than directed may cause drowsiness. Nervousness, dizziness or trouble sleeping can happen too. If any of these occur, stop and talk with your doctor.
📖 Read our full Loratadine / Pseudoephedrine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 5 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
37808-0787-07 You're viewing this Main listing 2 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK 2025-05-27 — Active
37808-0787-35 37808-787-35 3 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK 2025-05-27 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 2 blister pack in 1 carton / 5 tablet, extended release in 1 blister pack.
What NDC number is used to bill for this package of Allergy Relief-D LORATADINE AND PSEUDOEPHEDRINE SULFATE 240 mg; 10 mg Tablet, Extended Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
allergy d 10 mg/1; 240 mg 00113-9004-22 L. 1 tablet $0.553 — Availability likely —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 00904-5833-15 Major 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 46122-0167-52 Amerisource 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 46122-0383-22 AMERISOURCE 15 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 51660-0724-04 Ohm 5 tablets $0.553 — Availability likely —
Leader Allergy Relief D-24 10 mg/1; 240 mg 70000-0162-01 Cardinal 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 70677-1018-01 STRATEGIC 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 49348-0543-01 STRATEGIC 10 tablets $0.574 — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 62011-0071-01 Strategic 10 tablets $0.574 — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 00363-0725-15 Walgreen 15 tablets — — FDA listed —
Allergy Relief D 10 mg/1; 240 mg 00363-2010-22 Walgreen 1 tablet — — FDA listed —
Claritin-D 24 Hour 10 mg/1; 240 mg 11523-0102-01 Bayer 10 tablets — — FDA listed —
Claritin-D 24 Hour 10 mg/1; 240 mg 11523-4332-01 Bayer 5 tablets — — Discontinued —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 11822-9990-00 Rite 10 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 21130-0724-15 Safeway 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 30142-0724-15 The 1 tablet — — FDA listed —
allergy congestion relief 10 mg/1; 240 mg 30142-0846-22 Kroger 1 tablet — — FDA listed —
topcare allergy and congestion relief 10 mg/1; 240 mg 36800-0706-22 Topco 1 tablet — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 37808-0427-69 HEB 10 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 37808-0724-69 HEB 10 tablets — — FDA listed —
Allergy Relief-D 240 mg/1; 10 mgthis 37808-0787-07 HEB 5 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 41250-0724-52 Meijer 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 49035-0488-15 WAL-MART 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 51660-0491-15 Ohm 15 tablets — — Discontinued —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 56062-0724-15 Publix 15 tablets — — FDA listed —
Allergy Relief-D 10 mg/1; 240 mg 59779-0726-15 CVS 5 tablets — — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 63187-0305-10 Proficient 10 tablets — — FDA listed —
kirkland signature allerclear d 24 hr 10 mg/1; 240 mg 63981-0138-22 Costco 1 tablet — — FDA listed —
KIRKLAND SIGNATURE ALLERCLEAR D 24 HR Extended Release 10 mg/1; 240 mg 63981-0724-15 Kirkland-COSTCO 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 85766-0048-10 Sportpharm 10 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
May 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeOval
ImprintLPS
Size18 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Loratadine / Pseudoephedrine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII L11K75P92J
    A mineral salt made from calcium and phosphate. It acts as a filler and binder in tablets to add bulk and help hold the medicine together in solid form.
  • UNII 7Z8S9VYZ4B
    Ethylcellulose is a plant-derived thickener and film-former made by chemically modifying cellulose. It's used as a binder to hold tablet ingredients together, a coating to control how quickly medicine is released, or a thickener in liquid formulations.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII FZ989GH94E
    Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 46N107B71O
    Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesblack iron oxide, colloidal silicon dioxide, dibasic calcium phosphate anhydrous, ethyl cellulose, hypromellose, magnesium stearate, polyethylene glycol, povidone, propylene glycol, shellac

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerHEB
Application holderBIONPHARMA INC
FDA applicationANDA218017 (ANDA)
Labeler code37808
First marketedMay 2025
Product typeHuman Otc Drug
Portfolio89 products on file

More NDCs from HEB labeler code 37808

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 68 words ▾

Uses • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • sneezing •itchy, watery eyes • runny nose • itching of the nose or throat • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies • reduces swelling of nasal passages • temporarily relieves sinus congestion and pressure • temporarily restores freer breathing through the nose

⏱️ Dosage and Administration 53 words ▾

Directions • do not divide, crush, chew or dissolve the tablet adults and children 12 years and over 1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor

⚠️ Warnings 206 words ▾

Warnings Do not use • if you have ever had an allergic reaction to this product or any of its ingredients. • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product Ask a doctor before use if you have • heart disease • thyroid disease • high blood pressure • diabetes • trouble urinating due to enlarged prostrate gland • liver or kidney disease.

Your doctor should determine if you need a different dose. When using this product do not take more than directed. Taking more than directed may cause drowsiness.

Stop use and ask a doctor if • an allergic reaction to this product occurs. Seek medical help right away. • symptoms do not improve within 7 days or are accompanied by a fever • nervousness, dizziness or sleeplessness occurs If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📦 Storage and Handling 32 words ▾

Other information Safety sealed: do not use if individual blister unit is open or torn store between 20° to 25°C (68° to 77°F) protect from light and store in a dry place

🧪 Active Ingredient 14 words ▾

Active ingredient (in each capsule) Loratadine, USP 10 mg Pseudoephedrine sulfate, USP 240 mg

🧪 Inactive Ingredients 23 words ▾

Inactive ingredients black iron oxide, colloidal silicon dioxide, dibasic calcium phosphate anhydrous, ethyl cellulose, hypromellose, magnesium stearate, polyethylene glycol, povidone, propylene glycol, shellac

🎯 Purpose 4 words ▾

Purpose Antihistamine Nasal decongestant

📄 Do Not Use 73 words ▾

Do not use • if you have ever had an allergic reaction to this product or any of its ingredients. • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

📄 Ask a Doctor Before Use If 43 words ▾

Ask a doctor before use if you have • heart disease • thyroid disease • high blood pressure • diabetes • trouble urinating due to enlarged prostrate gland • liver or kidney disease. Your doctor should determine if you need a different dose.

📄 When Using This Product 17 words ▾

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

📄 Stop Use and Ask a Doctor If 40 words ▾

Stop use and ask a doctor if • an allergic reaction to this product occurs. Seek medical help right away. • symptoms do not improve within 7 days or are accompanied by a fever • nervousness, dizziness or sleeplessness occurs

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Questions or Comments 14 words ▾

Questions or comments? call toll free 1-888-235-2466 (Mon - Fri 9AM - 5PM EST)

📄 Package Label / Principal Display Panel 76 words ▾

15's carton Compare to CLARITIN-D® 24 HOUR active ingredients ƚ NDC 37808-787-35 H.E.B Allergy Relief-D Loratadine and Pseudoephedrine Sulfate Exrended-Release Tablets 10 mg/ 240 mg Indoor & Outdoor Allergies 24 Hour Non-Drowsy* Antihistamine/Nasal Decongestant Original Prescription Strength 15 days of Relief Relief of: • Nasal and Sinus Congestion Due to Colds or Allergies • Sneexing • Runny Nose • Itchy, Watery Eyes • Itchy Throat or Nose Due to Allergies 15 EXTENDED- RELEASE TABLETS 30's carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride — the ingredient across all brands.

Top reported reactions

Fatigue411
Pain404
Rash356
Abdominal Discomfort336
Alopecia329
Rheumatoid Arthritis324
Pemphigus322

Age at onset

Neonate9
Infant4
Child49
Adolescent39
Adult640
Elderly239

Reporter sex

2,995 reports
Male · 23%
Female · 77%

Serious outcomes

Hospitalization504
Disabling393
Life-threatening339
Death307
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 300 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by HEB. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 5 tablets (37808-0787-35). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
HEB is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 37808-0786-01 · HEB 37808-0792-01 · HEB →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.